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Interactions between host and gut microbial communities are modulated by diets and play
pivotal roles in immunological homeostasis and health. We show that exchanging the protein
source in a high fat, high sugar, westernized diet from casein to whole-cell lysates of the non-
commensal bacterium Methylococcus capsulatus Bath is sufficient to reverse western diet-
induced changes in the gut microbiota to a state resembling that of lean, low fat diet-fed
mice, both under mild thermal stress (T22 °C) and at thermoneutrality (T30 °C). Con-
comitant with microbiota changes, mice fed the Methylococcus-based western diet exhibit
improved glucose regulation, reduced body and liver fat, and diminished hepatic immune
infiltration. Intake of the Methylococcu-based diet markedly boosts Parabacteroides abun-
dances in a manner depending on adaptive immunity, and upregulates triple positive
(Foxp3+RORγt+IL-17+) regulatory T cells in the small and large intestine. Collectively, the-
se data point to the potential for leveraging the use of McB lysates to improve immuno-
metabolic homeostasis.
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Gut microbes shape intestinal immunity
1 and increase the
bioavailability of otherwise indigestible nutrients2. A well-
balanced community structure is therefore essential for
immunometabolic homeostasis, whereas aberrant gut microbiota
compositions associate with numerous diseases, both within and
outside the gastrointestinal tract3.
While therapeutic implications of rebalancing a mistuned gut
microbiota appear promising, inconsistent response rates in
relation to both probiotics and fecal transfer studies, with occa-
sional adverse events, emphasize the complexity of such
approaches. One example relates to the otherwise promising
probiotic candidate Akkermansia muciniphila4, where negative
effects have been seen in immunocompromised recipients5,6.
Similarly, Prevotella copri aids in metabolizing fibers in healthy
individuals7 and protects against bacterial invasion in high fiber,
chow-fed mice8, yet associates with insulin resistance in pre-
diabetic obese individuals and precipitates glucoregulatory
impairments in diet-induced obese (DIO) mice9.
An alternative to administering viable microbes is to utilize
whole-cell lysates, or selected cell components, of nonliving
bacteria. Apart from alleviating global energy demands, if used as
a nutrient source, such components may also potently affect host
physiology as recently reported for A. muciniphila10 and Bifido-
bacterium bifidum11. In the latter example, cell surface poly-
saccharides of B. bifidum were used to induce peripheral
immune-tolerance via generation of regulatory T cells (Tregs).
The authors reported a pronounced increase in Foxp3+RORγt+
Tregs (pTregs), specifically in lamina propria (LP) of the large
intestine (LI)11. This cell type is believed to be induced by
commensal microbes and has emerged as a potent Treg subset,
exhibiting increased lineage stability and enhanced immunosup-
pressive capacity during intestinal inflammation compared to
conventional Foxp3+RORγt- Tregs (nTregs)12.
RORγt is the canonical transcription factor controlling IL-17
expression; a pleiotropic cytokine with both proinflammatory and
immune resolving actions depending on the eliciting cell type and
physiological context13. Unfortunately, the studies describing
pTreg function did not measure IL-17 secretion. It therefore
remains unknown whether these cells exhibit normal, reduced or
increased IL-17 levels, and how this translates to host physiology.
The impact of this predominantly colonic cell subset on host
metabolism also remains unknown. Still, mounting evidence
points towards the importance of intestinal IL-17 for controlling
metabolic homeostasis14,15. IL-17+ pTregs may therefore be
leveraged as a ‘dual hit’ strategy to curb immunometabolic dys-
function and gastrointestinal disturbances based on the immune-
regulatory capacity of pTregs concomitant with the metabolic
benefits of gut-delivered IL-17.
To this end, we hypothesized that environmental bacteria, who
have not been under evolutionary scrutiny for host-microbe
interactions, would provide an unexplored reservoir of immu-
nomodulatory stimuli. In support of this hypothesis, the metha-
notropic noncommensal bacterium Methylococcus capsulatus
Bath (McB) has previously been shown to interact with human
dendritic cells (DC) modulating T cell responses in vitro16, and to
reduce inflammation and disease activity in dextran sulfate
sodium (DSS)-induced mouse colitis17. However, the impact on
host metabolism and intestinal immune cells as well as mucus
dynamics were not addressed.
We accordingly explored the effect of using whole-cell
lysates from McB as protein source to reshape immunometabo-
lism and the aberrant gut microbiota of DIO mice. We show
that McB lysates augment Foxp3+RORγt+IL-17+ triple-positive
pTregs in both SI- and LI-LP, and reset the obese microbiota
concomitant with reversed key disease traits of diet-induced
obesity.
Results
McB feeding reverses WD-induced gut microbiota changes and
increases cecal SCFA levels. To induce obesity and immuno-
metabolic dysfunctions, C57BL/6JRj mice were initially fed an
obesogenic WD. After 12 weeks of WD feeding, the mice were
stratified into new groups based on weight, fat mass and glu-
coregulatory capacity (Supplementary Fig. 1a), and fed experi-
mental WDs for an additional 6 weeks. While dietary fat is known
to elicit reproducible and lipid-dependent alterations in the
murine gut microbiome across a variety of different diet com-
positions18, less is known about the microbiota-modulating
impact of protein. Thus, to investigate if dietary protein (i.e.,
casein versus whole-cell bacterial lysates) would affect gut
microbiota community structures, we analyzed freshly collected
fecal samples before and throughout the dietary intervention.
LFD and WDREF fed mice showed distinct gut microbiota profiles
after 12 weeks of feeding (intervention baseline, week 12+ 0;
Fig. 1A, B), including ~10-fold lower abundance of the health-
promoting genera, Parasutterella19 and Parabacteroides20, coun-
tered by an equally increased abundance of the obesity-associated
genus Desulfivobrio21,22 (Fig. 1C) as well as a ~4-fold increase in
the Firmicutes to Bacteroidetes (F/B) ratio (Fig. 1D). Interestingly,
WDCNTL fed mice showed negligible changes in the microbiome
signature during the 6 weeks of intervention (Fig. 1A–E; Sup-
plementary Fig. 2a, b), suggesting that the added lipid source had
limited influence on the intestinal ecology. In contrast to this
observation, we noted a pronounced shift in bacterial composi-
tion in mice fed WDMcB. Within the first 2 weeks of treatment,
the general community structure in these mice shifted towards
that of their LFD-fed counterparts (Fig. 1A–E, Supplementary
Table 3). We next asked if the observed taxonomical differences
between groups related to alterations in the functional potential.
SCFAs are main end products of metabolized fibers, and to a
lesser extent amino acids escaping digestion in the SI, with vast
impact on host physiology23,24. The highest levels of SCFAs are
found in the cecum and proximal colon25. We therefore inves-
tigated if cecal SCFA levels were different between groups. We
found a consistent increase in the levels of the three major as well
as three minor classes of SCFAs in the cecum of WDMcB fed mice
compared to WDCNTL fed counterparts pointing towards not just
taxonomically, but also functionally, discrete microbiota profiles
in the two groups of mice, supporting a beneficial health impact
of dietary inclusion of McB lysates (Fig. 1F, G).
WDMcB feeding stimulates induction of gut-specific regulatory
T cells. The intricate relationship between gut microbes and host
immunity, combined with the immunoregulatory capacity of
SCFAs26, prompted us to investigate if the observed changes
mediated by WDMcB feeding were associated with immune
alterations.
We accordingly analyzed the immune cell profile of SI-LP and
LI-LP in a subset of experimental mice (n= 6–10/group) using
multicolor flow cytometry focusing on phenotypic characteriza-
tion of group 3 innate lymphoid cells (ILC3), natural killer (NK)
cells and T cells (consult Supplementary Fig. 3a, b for gating
strategies). Numbers of ILC3s, NK cells and T cell receptor
(TCR)-γδ+ T cells, were similar between groups (Supplementary
Fig. 3d–f). The same was true for the numbers of TCRβ+ CD4+
T cells, as well as the proportion of T helper (TH)1-, TH17-,
and nTregs cells (Fig. 2A, B; H, I). Interestingly, the proportion of
pTregs was more than 2- and 3-fold increased in LI- and SI-LP,
respectively of WDMcB fed mice compared to WDCNTL fed
counterparts (Fig. 2C, J p < 0.001; S3G). Notably, this regulatory T
cell subset has been shown to curb intestinal inflammation12 and
mediate immunological tolerance to the gut pathobiont
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Helicobactor hepaticus, thereby protecting against TH17-mediated
barrier dysfunction and subsequent colitis27. Because RORγt is
the hallmark transcription factor for TH17 cell differentiation and
essential for their IL-17 production, we next assessed if the pTregs
induced by the different diets were also capable of expressing IL-
17. Indeed, ex vivo stimulated pTregs produced substantial and
diet-dependent amounts of IL-17 protein, where WDMcB feeding
increased the proportion of IL-17+ cells within LI-LP pTregs
(Fig. 2D–G, p < 0.001; 2k-N; S3H). We confirmed gut-specificity
of the WDMcB-induced pTregs as only negligible amounts were
observed in single-cell suspensions of liver homogenates obtained
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prophylactically for 7 weeks (Supplementary Figs. 1c, 4a). pTregs
constituted <1% of all CD4+ T cells in the liver, hence contrasting
the ~3 and 20% in SI- and LI-LP, respectively, of LFD- and
WDREF-fed mice and stunning ~12 and 30% in similar sites of
WDMcB-fed mice (Supplementary Fig. 4b). Mechanistically, LI-,
but not SI-, LP-derived McB-induced pTregs exhibited enhanced
secretory capacity of the hallmark suppressive cytokine, IL-10,
upon ex vivo stimulation (Fig. 2O, consult Supplementary Fig. 3c
for gating strategy). Augmented IL-10 secretion was identified in
both nTregs and pTregs populations in LI-LP of WDMcB-fed mice
(Fig. 2O, P, p < 0.05 and <0.001, respectively), pointing towards
enhanced immune regulation following WDMcB feeding.
Although the absolute number of IL-10+n/pTregs was similarly
increased in SI-LP of WDMcB-fed mice (Supplementary Fig. 4c,
d), the relative proportion of IL-10+ cells within these Tregs
remained similar between groups (Fig. 2O, P). Collectively, these
data corroborate that the phenotypic shift of enhanced secretory
capacity was restricted to the colon of WDMcB-fed mice. The
amount of Ki67+ cells followed the patterns of pTreg abundances
(Fig. 2Q, R; Supplementary Fig. 4e, f, consult Supplementary
Fig. 3c for gating strategy).
WDMcB mitigates diet-induced obesity. The altered immune
profile combined with a shift of the gut microbiota towards a state
similar to that observed in lean LFD-fed mice, could potentially
elicit crosstalk to glucoregulatory organs. To examine if McB
lysates could reverse impaired glucose regulation, we performed
OGTT and assessed GSIS concomitant with body mass compo-
sition in obese mice fed WDREF for 11 weeks and after 5 weeks of
dietary intervention allowing for temporal analyses (Supple-
mentary Fig. 1a). All mice were stratified into experimental
groups based on their pre-intervention glucoregulatory capacity
(Supplementary Fig. 4g, h). While the response to glucose chal-
lenge remained largely unaffected from week 11 to week 12+ 5,
regardless of experimental diets (Fig. 3A–C), both 5 h fasted
insulin levels and glucose-stimulated insulin responses were sig-
nificantly increased in mice fed WDCNTL (Fig. 3E, p < 0.01 &
p < 0.001, respectively) in accordance with our previous report on
time-dependent alterations in glucose regulation28. LFD- and
WDMcB-fed mice were fully protected against this detrimental
trajectory (Fig. 3D–F; Supplementary Fig. 4i, p= 0.24 and 0.68,
respectively), and WDMcB-fed mice further exhibited modestly
improved insulin sensitivity based on 5 h fasted glycemia (Fig. 3C,
p < 0.05) and intraperitoneal insulin tolerance test (Fig. 3G,
p < 0.05).
Overall, weight development mimicked the glucoregulatory
capacity. As such, WDMcB-fed mice exhibited stability of weight,
fat mass and lean mass when changed to experimental diets,
contrasting the continuous weight and fat mass development of
WDCNTL-fed mice (Fig. 3H, I and Supplementary Fig. 4j). The
absence of weight gain was not explained by decreased feed
intake, but rather appeared to be associated with enhanced fecal
energy secretion (Fig. 3J, K).
Since obesity and impaired glucose regulation are tightly
associated with NAFLD29, we next subjected paraffin-embedded
liver sections to histological evaluation. These analyses revealed
both diminished steatosis and hepatocellular ballooning in
WDMcB-fed mice compared to WDCNTL-fed counterparts, where
especially hepatocellular ballooning was arrested in (or returned
to) a state reminiscent that of lean LFD-fed mice (Fig. 3L, M,
p < 0.05). Importantly, hepatocellular ballooning is instrumental
in the development of the more severe liver disease, NASH29.
WDMcB feeding resets the hepatic lipidome and decreases
hepatic immune infiltration alleviating NAFLD. Based on the
decreased NAFLD in WDMcB-fed mice housed at T22°C we
designed a new experiment (study outline, Supplementary
Fig. 1b) using a recently described30 method where thermoneutral
housing (T30°C) potentiates NAFLD in WT C57BL/6 J mice fed an
obesogenic diet for 20–24 weeks. To more thoroughly investigate
the effect of WDMcB-feeding, we also redesigned the diets and
omitted macadamia oil in the WDCNTL group, as this might lead
to progression of obesity (Fig. 3) and related disorders. This new
diet design entailed an increased fat/protein ratio in WDMcB
compared to WDREF, due to phospholipids inherently present in
bacterial lysates31 (Supplementary Table 1). Despite the lower
protein content in WDMcB compared to both other diets, the
relative amounts of indispensable amino acids were similar
between groups (Supplementary Fig. 1f) and protein availability
was well beyond critical levels, corroborated by similar lean mass
to WDREF-fed mice post diet intervention (Supplementary
Fig. 5a). Still, WDMcB-fed mice exhibited significantly improved 5
h fasting insulin levels and decreased fat mass (Fig. 4A, B), despite
weight maintenance and significantly increased energy intake
compared to both LFD and WDREF-fed mice (Supplementary
Fig. 5b–d). The decreased body fat mass was accompanied by a
diminished NAS, supported by both pathological evaluation of
H&E stained liver sections (Fig. 4C, D) and hepatocytic lipid
content assessed by Oil-Red-O staining (Fig. 4E–G). We addi-
tionally observed augmented adiponectin secretion (Fig. 4H),
Fig. 1 McB feeding reverses WD-induced gut microbiota changes and increases cecal SCFA levels. A Principle coordinate analysis (PCoA) using
Weighted UniFrac distances of fecal microbiota sampled from first and second experiment biweekly during the dietary intervention period, as indicated by
numbers post dietary intervention in centroids. The WDCNTL and WDMcB groups were similar in microbiota composition prior to dietary intervention week
12+ 0 (PERMANOVA p= 0.88 and 0.43 in Exp1 and Exp2, respectively). At the end of each experiment, the microbiota composition was significantly
different between these groups (PERMANOVA p= 0.001 and 0.002 in Exp1 and Exp2, respectively). B Taxasummary of most abundant bacterial genera
showing mean relative abundance in % of indicated family and genera in each group at indicated time points. C Deseq analysis of fecal bacterial genera
abundances significantly regulated by McB intervention compared to the WDCNTL (p.adj. < 0.05). Relative abundance in % in each group and variation are
shown for each regulated genus at the sampled time points. Fold-change and adjusted p values of individual genera are indicated in Supplementary Table 3.
D Relative Firmicutes/Bacteroidetes ratio of fecal samples of individual mice before (12+ 0) and after 6 weeks of dietary intervention (12+ 6). Statistical
significance is indicated by p value on Wilcoxon matched-pairs signed rank test. E Weighted UniFrac distance (instability test) between paired samples
from indicated 2-weeks’ interval post dietary intervention. Statistical significance is indicated by p value on RM two-way ANOVA with multiple comparison
and Bonferroni’s post-hoc. D, E LFD n= 6, WDCNTL and WDMcB n= 15 per group. F Major short-chained fatty acids (SCFAs) in cecal content as fold-
change pmol per cecum. Propionate data was tested by one-way ANOVA and Dunnett’s multiple comparisons test. Acetate and butyrate data was tested
by Kruskal–Wallis test and Dunn’s multiple comparisons test. LFD n= 6, WDCNTL n= 11, and WDMcB n= 10. G Minor SCFAs in cecal content as fold-
change pmol per cecum. Isobutyrate and isovalerate data were tested by Kruskal–Wallis test and Dunn’s multiple comparisons test. Valerate data were
tested by one-way ANOVA and Dunnett’s multiple comparisons test. LFD n= 6. WDCNTL and WDMcB n= 10 per group. D–G Bars indicate group mean ±
SEM and individuals data points in Exp1 (squares) and Exp2 (circles) with p-values < 1 × 10−1 between WDCNTL and indicated group using the specified
statistical test.
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Fig. 2 WDMcB feeding stimulates induction of gut-specific regulatory T cells. A–D Number of indicated cells in colon. E–G Representative plots of colonic
TCRβ+CD4+ FoxP3+ RORγt+ pTregs (left) and IL-17+ pTregs (right) in LFD (E), WDCNTL (F), and WDMcB (G) group. H–K Number of indicated cells in small
intestine. L–N TCRβ+CD4+ FoxP3+ RORγt+ pTregs (left) and IL-17+ pTregs (right) in LFD (L), WDCNTL (M), and WDMcB (N) group. O–R Percentage of
indicated cells in SI- and LI-LP from ‘weight-matched’ mice housed at thermoneutrality. A–N Dots indicate individuals data points in Exp1 (squares) and
Exp2 (circles) with n= 6 (LFD) or 10 (WDMcB and WDCNTL). O–R SI-LP n= 5 per group and LI-LP n= 9 (LFD and WDREF groups) or 11 (WDMcB).
A–D, H–K, O–R Bars indicate group mean ± SEM and dots indicate individual data points. All p-values < 1 × 10−1 between WDCNTL and indicated group by
one-way ANOVA with multiple comparisons and Dunnett post-hoc are depicted.
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pointing towards improved insulin sensitivity in the WDMcB
group, further supported by the assessment of insulin
tolerance and hepatic gene transcription activity of key metabolic
enzymes (Fig. 4I, J). Of interest, we observed a >10-fold down-
regulation of Scd1 in the liver of WDMcB-fed mice, the hepatic
expression of which is (a) regulated by the microbiota32 and (b)
instrumental in de novo lipogenesis at the onset of metabolic
syndrome33.
We next assessed the hepatic lipidome by tandem mass
spectrometry to elucidate if diminished NAFLD was associated
with an altered lipid profile. Through comparison of WDMcB and
WDREF we identified 57 and 279 differentially regulated peaks in
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negative and positive ionization mode, respectively (Fig. 5A, B;
Supplementary Fig. 5e, f, all FDR < 0.05). Of these, most classified
lipids were changed with WDMcB in the direction of LFD-fed
mice (Fig. 5C, D). Notably, 57% of upregulated species were odd-
chain fatty acids, whereas 80% of downregulated species
represented lipids with even carbon numbers (Fig. 5C, D and
Supplementary Table 4), hence supporting previous reports
where odd- rather than even-chain fatty acids are inversely
associated with human insulin resistance9 and type 2 diabetes34.
To estimate the functional consequences of an altered lipid
profile, we used the Lipidmaps database to identify affected
pathways and plotted the observed changes on a log2 scale
comparing both LFD and WDMcB to WDREF. The majority of
affected pathways was similarly regulated in both direction and
magnitude in LFD and WDMcB mice compared to WDREF mice
(Fig. 5E; Supplementary Fig. 5g). Notably, bile acids and
ceramides, both of which were significantly downregulated in
WDMcB-fed mice compared to WDREF-fed counterparts, have
been shown to mediate steatohepatitis by upregulation of IL-6
and TNF-α, respectively35,36. We therefore measured these
hepatic cytokines and observed similarly reduced levels in both
LFD and WDMcB compared to WDREF (Fig. 5F).
A key feature of diet-induced liver pathologies, including
NAFLD, is recruitment of newly activated immune cells capable
of eliciting a proinflammatory immune response. This process is
generally hampered in mice housed at mild thermal stress, which
therefore fail to phenocopy human pathophysiology. However,
thermoneutral housing recapitulates some human disease traits37,
which combined with HFD-feeding accentuates intrahepatic
infiltration of proinflammatory Ly6high monocytes38. These
monocytes interact with tissue resident T cells and play a central
role in the pathogenesis of liver injury, hence representing an
attractive therapeutic target to mitigate NAFLD development and
to curtail associated pathologies36.
We therefore subjected liver tissues from representative mice to
immunological evaluation by immunohistochemistry and
observed a marked decrease in both CD3+ T cells and Ly6G+
neutrophils in WDMcB-fed mice compared to their WDREF-fed
counterparts (Fig. 5G). Diminished hepatic immune
infiltration was mirrored by increased levels of circulating IL-
22, IL-18, and IL-17 in WDMcB-fed mice compared to their
WDREF-fed counterparts (Fig. 5H, p < 0.01, <0.05, and <0.05,
respectively).
We next initiated a short term experiment in ‘weight-matched’
mice to evaluate the hepatic immune profile before obesity onset
(Supplementary Figs. 1C; 5h, i). Surprisingly, this experiment
revealed increased numbers of tissue resident Tim4+ macro-
phages (i.e., Kupffer cells) in WDMcB-fed mice, suggesting that
McB feeding either recruits or stimulate in situ proliferation of
this key cell subset driving hepatic homeostasis (Fig. 5I). Kupffer
cells are central to innate immunity and responsible for
containment and clearance of foreign particles. Inflammatory
activation of hepatic Kupffer cells potentiates obesity-associated
insulin resistance, in part by recruiting neutrophils and T cells39.
Yet, Kupffer cells exhibit tremendous plasticity in their activation
program, with anti-inflammatory properties in their alternative
activation state ameliorating hepatic steatosis40. While our
staining panel did not allow us to identify the activation state
of the enhanced Kupffer cell proportions, it is pertinent to note
that none of the classically recruited cell types were altered in
numbers (Supplementary Fig. 5j, k). Instead, we observed
increased proportion of Ly6C+ monocytes. The mean fluores-
cence intensity (MFI) within these monocytes was marginally
lower in WDMcB-fed mice than in their WDREF-fed counterparts
(Fig. 5J). Newly recruited monocytes express high levels of Ly6C
in their inflammatory state; an expression that is gradually
downregulated in immune resolving alternatively activated
cells36,41,42. Despite weight maintenance, WDREF-fed mice
exhibited ~50% increase in hepatic IL-17+ γδ T cells (Fig. 5K),
an immunological precursor for subsequent NAFLD controlled
by the gut microbiota43. WDMcB-fed mice were fully protected
from this trait, pointing towards extraintestinal regulation of
innate immunity key to metabolic homeostasis.
WDMcB feeding reverses prolonged gut microbial dysbiosis and
markedly improves colonic mucus production. The improved
hepatic phenotype prompted us to further investigate potential
traits in the gut-liver axis. We initially assessed if the observed
cytokine responses associated with improved gut health in mice
housed at T30°C, where inflammation is expected to be
increased37. Indeed, WDMcB-fed mice were resistant to WD-
induced colonic shortening closely associated with colonic
inflammation (Fig. 6A).
To gain additional insights to the immunomodulating proper-
ties of McB lysates, we focused on mucus production and
-function. Because mucin production is a constitutive process
Fig. 3 Dietary intervention with McB blunts progression of insulin resistance and fat mass accumulation. A–C Oral glucose tolerance test (OGTT) and 5
h fasting blood glucose prior to dietary intervention (Week 11) and 5 weeks post intervention (Week 12+ 5) of LFD (A), WDCNTL (B), and WDMcB (C)
groups. D–F Glucose-stimulated insulin concentration during OGTT and 5 h fasting insulin levels prior to dietary intervention (Week 11) and 5 weeks post
intervention (Week 12+ 5) of LFD (D), WDCNTL (E), and WDMcB (F) groups. G Intraperitoneal insulin tolerance test (ITT) 3 weeks post dietary
intervention. H Body weight development. Mice were fed either LFD or WDREF the first 12 weeks followed by 6 week dietary intervention period. Dotted
vertical line depicts intervention start. I Fat mass in gram through the dietary intervention period (Week 12+ 0 to 12+ 6) measured by MR scan. J Feed
intake per cage as average grams per mouse during 48 h. K Fecal content of fat and protein. L NAFLD activity score based on hepatic steatosis grade (0–3),
inflammation (0–2), and hepatocellular ballooning (0–3) graded by blinded histological assessment of liver tissue. M One representative H&E stained
picture per group out of 6 (LFD) or 13 (WDMcB and WDCNTL) liver tissue sections. A, F n= 6 (LFD) and 15 (WDMcB and WDCNTL) except for F timepoint
60–120min at Week 11 where n= 14, 12, and 12, respectively due to insufficient sample material. Statistical significance within each timepoint is indicated
by p values at paired two-way ANOVA-RM with Bonferroni post-hoc test. Fasting glucose and insulin levels were evaluated by paired t-tests. Lines indicate
group means and dots represents individual data points. G n= 8 (WDMcB) and 9 (WDCNTL). WDMcB was compared to WDCNTL by two-way ANOVA-RM
with Bonferroni post-hoc test. Lines indicate group means and dots represents individual data points. H–I n= 6 (LFD) or 15 (WDMcB and WDCNTL). LFD and
WDMcB were compared to WDCNTL by two-way ANOVA-RM, adjusted for multiple comparisons by Dunnett’s post-hoc. Lines indicate group means and
dots represents individual data points. J, K Each data point represents the average of one cage. n= 2 (LFD) to 5 (WDMcB and WDCNTL). LFD and WDMcB
were compared to WDCNTL by one-way ANOVA, adjusted for multiple comparisons by Dunnett’s post-hoc. Dot shapes indicate individuals data points in
Exp1 (squares) and Exp2 (circles). L Bars represent median and interquartile range and dots represents individual data points. All p-values < 1 × 10−1
between WDCNTL and indicated group are depicted. Dot shapes indicate individuals data points in Exp1 (squares) and Exp2 (circles). LFD and WDMcB were
compared to WDCNTL by Kruskal–Wallis, adjusted for multiple comparisons by Dunn’s post-hoc. n= 6 (LFD) or 13 (WDMcB and WDCNTL). A–L All p-values
< 1 × 10−1 between WDCNTL and indicated group are depicted.
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where both secretion and adherence are constantly ongoing and
rapidly adjust to environmental changes, immunohistochemical
labelling for various MUC epitopes may not fully recapitulate the
physical properties of the mucus. We therefore applied
specialized mucin histochemistry staining allowing us to
differentiate between neutral and acidic mucins according to
the net charge of each molecule. Acidic mucins were further
separated into sulfomucins and sialomucins. Sections revealed
that neutral mucins in crypt-residing goblet cells were consis-
tently downregulated in WDREF-fed mice compared to LFD-fed
counterparts in three well defined segments of the colon; i.e.
proximal, middle and distal area (Fig. 6B, D). WDMcB-feeding not
only reversed this pattern in all three segments but even also
enhanced the production of neutral mucins exceeding the levels
found in LFD- fed counterparts. This is a remarkable finding
considering the continuous intake of a westernized diet high in fat
and sucrose, known to hamper goblet cell function. We next
evaluated crypt depth (CD) in stained sections. While the CD of
the proximal and distal part of the colon was largely unaffected by
diet, we observed increased CD in the middle segment of WDMcB-
fed mice (Fig. 6C). WDMcB-feeding further enhanced the
glycosylation pattern, particularly in the middle segment of
colon, where this group exhibited a 3-fold increase in sulfomucins
balanced by a similar (~2-fold) decrease in sialomucins compared
to WDREF-fed mice (Fig. 6E–G). No differences were observed
between WDREF and LFD-fed mice, indicating that the reciprocal
regulation of mucin glycosylation status was specific to WDMcB-
feeding.
With focus on the dynamic interactions between gut immunity,
mucin glycosylation and commensal microbes44, we next assessed
the gut microbiota composition in temporally separated samples.
This was done to determine if the changes towards a gut
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microbiota resembling that of lean LFD-fed mice was recapitu-
lated in this intensified setup. In contrast to the first set of
experiments, where we used cohoused mice shown to exhibit
resilient microbiota profiles, we now employed single-housed
mice to explore if the WDMcB-mediated community structures
were persistent enough to induce consistent changes in the more
dynamic communities of single-housed mice. Similar to our first
experiments at T22°C, we observed a normalization of the gut
microbiota of WDMcB-fed mice, despite prolonged WD feeding
prior to intervention (Fig. 6H–K). WDMcB-induced changes were
surprisingly consistent with the first set of experiments, including
a significantly lower F/B ratio (Fig. 6J), and a substantial
reduction of Desulfovibrio abundance, countered by a similar
bloom of the Parasutterella and Parabacteroides genera (Fig. 6K,
Supplementary Table 5). Of note, the age-related increases in
Desulfovibrio abundances recently reported21 was confirmed in
this study where the general magnitude in both WDREF- and
LFD-fed mice increased 2-3-fold over the 5 week intervention
(Fig. 6K). WDMcB-feeding fully prevented this trajectory and
paired analyses even revealed a diminished relative abundance of
Desulfovibrio in these mice.
McB lysates rely on adaptive immunity to favor Para-
bacteroides blooms. To assess if WDMcB-induced microbiota
alterations were a result of diminished obesity or altered immu-
nity we next evaluated the impact of WDMcB-feeding in ‘weight-
matched’ C57BL6/N mice fed the respective diets for 7 weeks
(Supplementary Fig. 1c). In agreement with previous reports,
WDREF feeding induced a ~3-fold decrease in Parabacteroides
abundance independent of obesity, a feature that has been
reported in several immune-competent mouse strains45. WDMcB
feeding not only prevented this trajectory but selectively
enhanced the relative abundance of this genus > 10-fold (Fig. 7A,
C; Supplementary Fig. 6a). The WDMcB-induced change in
Parabacteroides abundance shifted the microbiota consortium
away from their WDREF-/LFD-fed counterparts (Fig. 7D, G).
Considering the marked pTreg phenotype, we next evaluated
microbial structures in RAG2−/− mice deficient in adaptive
immunity. Here, mice on LFD (Week 0) exhibited diminished
Parabacteroides abundance as compared to their WT counter-
parts (Fig. 7A–C, E). Strikingly, WDMcB feeding was incapable of
boosting the relative abundance in RAG2 deficient mice, indi-
cating that the selective increase reported above was mediated by
WDMcB through adaptive immunity, hence potentially by pTreg
induction (Fig. 7B, E). The reciprocal actions on Desulfovibrio
abundance was on the contrary independent of adaptive immu-
nity (Fig. 7A, B; Supplementary Fig. 6a, b).
Despite some synergies between McB and T/B cells in affecting
specific gut microbes (i.e., Parabacteroides), the global changes to
microbial community structures induced by WDREF-feeding in
both WT and RAG2-/- mice was generally mitigated by WDMcB-
feeding. These traits include a diminished F/B ratio in WDMcB-
fed RAG2-/- mice (Supplementary Fig. 6c). Collectively, these
findings suggest that the vast majority of WDREF-induced
changes and the McB-mediated protection against these, were
independent of adaptive immunity (Fig. 7A–H; Supplementary
Fig. 6a, b).
Altered gut microbiota by WD feeding affects glucose regula-
tion. Despite a general protection against WD-induced global
changes in the gut microbiota, the specific and substantial
changes in key driver species (e.g., Parabacteroides) by WDMcB
feeding solely in WT mice, could suggest that some of the
metabolic effects reported above was mediated by the selective
increase in pTregs. We thus evaluated glucoregulatory capacity in
RAG2−/− mice fed either diet for 6 weeks and observed a partial
protection against WD-induced 5 h fasted hyperinsulinemia,
insulin secretion during OGTT, body weight gain, and total fat
mass (Fig. 8A–G). Both cecum weight and SCFAs were further
enhanced to levels resembling those in the above-reported WT
mice (Fig. 8H, I). Collectively, these data suggests that at least
some of the metabolic effects observed in WDMcB-fed mice may
occur independent of adaptive immunity.
We therefore designed CMT experiments in ABX treated mice
and assessed the glucoregulatory capacity in cohorts fed either
LFD or WDREF (Supplementary Fig. 1e). While we failed to
observe a donor-dependent effect of CMT in LFD-fed mice
(Fig. 8J, K; Supplementary Fig. 6d–g), we did observe transient
tendencies of metabolic improvements, notably on fat mass and
GSIS, in WD-fed mice receiving cecal microbes from LFD- or
WDMcB-fed donors (Fig. 8K–O).
Discussion
In this report, we explored the relationship between dietary
nutrients and host-microbe interactions with a focus on immu-
nometabolic response rates in the context of high fat, high
sucrose, WD feeding. We found whole-cell lysates from the
noncommensal methanotrophic bacterium, McB, capable of
reversing hallmark signatures of WD feeding despite continued
Fig. 4 Dietary McB intervention improves diet-induced metabolic and hepatic phenotype after prolonged WD feeding. A 5 h fasting plasma insulin
levels before (Week 20) and after (Week 21+ 5) dietary intervention. Dots represents individual data point and bars represents mean ± SEM. n= 7 (LFD)
or 9 (WDREF and WDMcB). LFD and WDMcB were compared to WDCNTL by paired t-test. B Fat mass in grams measured by MR scan at indicated time
points from dietary intervention. Dots represents individual data point and lines depicts mean. n= 10 (LFD and WDMcB) or 9 (WDREF) per group. C NAFLD
activity score separated in hepatic steatosis grade (0–3), inflammation (0–2) and hepatocellular ballooning (0–3) graded by blinded histological
assessment of H&E stained liver tissue. Dots represents individual data point and bars represent median and interquartile range. n= 10 (LFD) or 9 (WDREF
and WDMcB) per group. D One representative H&E stained picture per group out of 10 (LFD) or 9 (WDREF and WDMcB) liver tissue sections. E Number of
lipid droplets in each liver sample per experimental group quantified by Oil Red O staining. Dots represents individual data point of 3 (LFD and WDREF) and
4 (WDMcB) randomely chosen samples; bars represent median and interquartile range. F Average size of lipid droplets in each of 3-4 liver samples per
experimental group quantified by Oil Red O staining in (E). Dots represents individual data point of 3 (LFD and WDREF) and 4 (WDMcB) randomely chosen
samples; bars represent median and interquartile range. G Distribution of lipid droplet size in % of all lipid droplets within each experimental group from
E. H Plasma adiponectin concentration in 5 h fasted mice before (Week 20) and after (Week 21+ 5) dietary intervention. Dots represents individual data
point and bars represents mean ± SEM. n= 8 (LFD), 7 (WDREF), or 6 (WDMcB). I ITT after four weeks of dietary intervention (Week 21+ 4). Dots
represents individual data point and lines depicts mean. n= 7 (LFD), 9 (WDREF), or 10 (WDMcB). J Expression of key metabolic enzymes in liver tissue after
5 weeks of dietary intervention (Week 21+ 5) by RT-qPCR. Dots represents individual data point and bars represents mean ± SEM. n= 10 (LFD and
WDMcB) or 8 (WDREF) per group. A, H Statistical significance compared by paired t-test. B, I Statistical significance compared to WDREF by two-way
ANOVA-RM, adjusted for multiple comparisons by Dunnett post-hoc. C, E, F, J Statistical significance compared to WDREF by Kruskal–Wallis test, adjusted
for multiple comparisons by Dunn’s post-hoc. A–J All p-values < 1 × 10−1 between WDREF and indicated group are depicted.
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intake of an obesogenic diet. The signatures included diminished
fat mass, improved intestinal immunity and glucoregulatory
capacity accompanied by gut microbial community structures
resembling that of lean LFD-fed counterparts.
The aberrant microbiota composition associated with obesity
was recently shown to reflect HFD intake rather than obesity
per se45. It is therefore worth noting that we were able to
normalize the dysregulated gut microbiota in mice remaining on
a westernized, high fat, high sucrose diet; especially considering
that it remains a clinical challenge to change dietary habits in
individuals with lifestyle-related obesity. This remarkable change
was reproduced in four substrains of mice originating from two
different vendors, corroborating a robust phenotype not notably
affected by baseline microbiota composition. To this end, a
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previous report on the resilience of the microbiota, argued for
prolonged normalization46. This study found that mice trans-
ferred to a low fat, fiber-rich chow diet after 12 weeks of HFD
feeding, shifted their microbiota towards age-matched chow-fed
control mice within 4 weeks, but only fully converged 10 weeks
post diet change. This is particularly interesting as dietary fibers
are known to be the most potent dietary regulator of the gut
microbiota47, by far exceeding that of dietary fat48. Still, in our
hands, WDMcB-feeding was able to reverse the obese microbiota
at a higher pace than chow diet was in the previous report46,
despite similar fiber content in the two WDs. We further showed
that the reversal of the microbiota traits was reproducible at
different temperatures, altered reference diets, changed experi-
mental duration, and in both cohoused and single-housed mice;
all of which are prominent modulators of gut microbiota com-
munity structures. While many genera were similarly affected
between experiments, others were either exclusively regulated at
T30°C (e.g., Bifidobacterium) or less pronounced affected at T30°C
(e.g., Barnesiella), suggesting dispensability for these specific
microbes in the metabolic disease traits observed in this model.
Similar observations were made for Akkermansia, which was ~3-
fold upregulated at T30°C, but discordantly affected (log2 FC
bouncing from +9.3 to −10.4) between the two replication stu-
dies at T22°C with pronounced intragroup variation.
Contrasting these discrepancies, there was a consistent down-
regulation of Desulfovibrio accompanied by >10-fold upregulation
of Parabacteroides and Parasutterella in immunocompetent mice
when changed from either WDCNTL or WDREF to WDMcB feed-
ing. Our prophylactic experiment further showcased how Para-
bacteroides remained stable in LFD-, decreased in WDREF- and
dramatically increased in WDMcB-fed mice (~30-fold higher
relative abundance than WDREF-fed counterparts). Para-
bacteroides blooms were exclusively regulated in immuno-
competent mice, suggesting that WDMcB feeding promotes
selective microbial traits by McB-T/B cell interactions, and this
likely through the pronounced induction of IL-10+/IL-17+ gut-
specific pTregs, being the only investigated cell subset that was
notably changed upon WDMcB feeding. It is worth noting, that
not only was the prevalence of Parabacteroides not different
between all groups and time points in RAG2-/- fed mice, the
relative abundance of this genus in these mice was also lowered to
a level resembling that of WDREF-fed WT mice, hence pointing
towards a strong involvement of adaptive immunity to support a
Parabacteroides favorable ecological niche. Other commensals,
such as Barnesiella, Allobaculum, Clostridium IV, and Desulfovi-
brio remained as Parabacteroides stable over time in LFD-fed
mice, but were substantially and inversely regulated between
WDREF- and WDMcB-fed mice (Supplementary Fig. 6a, b). The
feed and time-dependent trajectories of these specific bacteria
were independent of adaptive immunity and thus similarly
regulated in both WT and RAG2−/− mice. Interestingly, Desul-
fovibrio was most recently shown to flourish in aged, immuno-
compromised, obese mice with impaired glucose regulation21.
Both T cell loss and Desulfovibrio administration per se, pre-
cipitated obesity-induced insulin resistance21. Still, in our hands,
Desulfovibrio abundances neither were notably affected by the
absence of T cells in RAG2−/− mice, nor were the suppressive
capacity of our McB lysate. This bacterium has moreover been
shown to thrive in desulfonated colonic mucosa, associated with
human49 and mouse50 colitis. Combined, these observations lend
credence to the hypothesis of a mechanistic link between WDMcB-
mediated reductions of Desulfovibrio and the observed
improvements in mucin chemotype and metabolic response rates.
In support of this notion, we observed a partial protection against
WD-induced metabolic impairments in WDMcB-fed RAG2−/−
mice concomitant with Desulfovibrio suppression. Further
pointing toward a role for the McB-induced microbiota changes
to modulate host metabolism, WDREF-fed, ABX treated recipient
mice in CMT studies temporally exhibited a phenotype visually
resembling that of their donors. Despite following a protective
trajectory, the phenotype remained insignificant, likely due to a
combination of the inherent variation in such experiments,
a rather low n-number based on sample availability, and only a
partial involvement of the gut microbial community structure in
the precipitated phenotype.
Future studies are warranted to elucidate host-microbe mutu-
alism upon WDMcB feeding. On this note, mucin-producing
goblet cells are capable of delivering luminal antigens to LP-
residing DC51 instrumental for T cell polarization52. As McB
potently induce DC maturation markers in vitro—even exceeding
the effects of the well-described probiotic strain, Escherichia coli
Nissle 191753—affecting subsequent T cell reponses16, we predict
a direct link between McB intake and the corresponding immune
profile, which might subsequently precision edit certain microbes,
e.g., Parabacteroides.
In addition to the direct link proposed here, McB intake might
also indirectly promote Treg polarization through augmented
SCFAs54, a trait persisting in RAG2−/− mice. These important
metabolites also sustain mucus production and facilitate tissue
crosstalk in the gut-liver axis2. In keeping with this notion, we
observed decreased hepatic bile acids and TNF-α levels combined
with a pronounced reduction of intrahepatic CD3+ and Ly6G+
cells in obese WDMcB-fed mice. Importantly, while Ly6Chigh cells
represent proinflammatory, fibrogenic macrophages55, their
in situ differentiation to Ly6Clow cells41 facilitate tissue repair and
improved NASH prognosis42. It is therefore encouraging to note,
that the MFI of Ly6C was nominally decreased in ‘weight-mat-
ched’ mice fed WDMcB short term. These data indicate that,
despite being increased in absolute numbers, Ly6C+ cells in
WDMcB-fed mice were in the process of differentiating from
Fig. 5 WDMcB feeding resets the hepatic lipidome and decreases hepatic immune infiltration alleviating NAFLD. A Principle coordinate analysis (PCoA)
of hepatic lipid species identified in negative ionization mode. B As in A but depicted in a volcano plot with significantly regulated lipid species (FDR < 0.05,
adjusted for multiple comparisons by Benjamin–Hochberg) presented on a log2 scale in either green (WDMcB >WDREF) or blue (WDMcB <WDREF).
C, D Identified lipid species differentially expressed (FDR < 0.01) between WDMcB and WDREF as indicated. Adjusted p values of individual lipid species are
indicated in Supplementary Table 4. n= 10 (LFD and WDMcB) or 9 (WDREF). E Lipid pathways identified by fold-change analysis (FDR < 0.05, adjusted for
multiple comparisons by Benjamin–Hochberg) seperating LFD (gray) and WDMcB (green) groups from WDREF in negative ionization mode. F Hepatic
cytokine levels of TNF-α and IL-6 as indicated. n= 9 (LFD and WDMcB) and 8 (WDREF). G Ly6G+ and CD3+ immune cells revealed by
immunohistochemistry. n= 3 per group (randomly selected samples). H Cytokine levels in plasma of IL-22, IL-18, and IL-17. n= 10 (LFD and WDREF) or 8
(WDMcB). I Amount of Tim4+ Kupffer cells. n= 8 (LFD), 9 (WDREF), and 11 (WDMcB). J Mean Fluorescence intensity (MFI) of Ly6C+ liver monocytes. n=
8 (LFD), 9 (WDREF), and 11 (WDMcB). K Amount of hepatic IL-17+ γδ T cells. n= 8 (LFD), 9 (WDREF), and 11 (WDMcB). C, D, F–K Bars represent group
mean ± SEM and dots indicate individual data points. F, H Statistical significance compared to WDREF group by Kruskal–Wallis test, adjusted for multiple
comparisons by Dunn’s post-hoc. G, I–K Statistical significance compared to WDREF by one-way ANOVA, adjusted for multiple comparisons by Dunnett
post-hoc. All p-values < 1 × 10−1 between WDREF and indicated group are depicted.
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Ly6Chigh to Ly6Clow cells with immune resolving capabilities,
although further studies are warranted to fully describe the
kinetics in such responses. In agreement with an immune resol-
ving phenotype, WDMcB-fed mice were fully protected from the
~50% increase in hepatic IL-17+ γδ T cells observed in WDREF-
fed counterparts before the onset of obesity. This cell subset has
been shown to (a) be regulated by the gut microbiota and (b) both
precede and causally induce NAFLD43. The above affected targets
are all proposed as relevant strategies to curb NAFLD and the
more terminal liver disease, NASH36.
The substantial, consistent, and global changes in the immu-
nometabolic profile found in this study point towards clinical
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potential if further developed. Notably, only a single study has
previously succeeded in inducing pTregs, and this was limited to
LI-LP11. Apart from inducing this cell subset throughout the
gastrointestinal tract, we further show that these cells exhibited
enhanced secretory capacity of both the hallmark immunosup-
pressive cytokine, IL-10, as well as IL-17 in LI-LP of WDMcB-fed
mice compared to their WDCNTL fed counterparts. To this end,
emerging evidence indicates that the non-regulatory counterparts
to pTregs, i.e. TH17 cells, are purged from SI-LP in DIO mice14 and
that reintroducing ex vivo differentiated gut tropic TH17 cells
curtail obesity development, hence improving insulin sensitiv-
ity15. Notably, despite intergroup similarities in the relative pro-
portion of SI-LP IL-10+/IL-17+pTregs, the absolute numbers of
these cells were markedly increased in WDMcB-fed mice, thus
advocating enhanced immune regulation.
That IL-17 in this intervention is produced by Tregs and not
TH17 cells might further improve the safety profile of a putative
medication, as the physiological impact and properties of TH17
cells are context-dependent. As such, TH17 cells may potentiate
inflammatory bowel disease (IBD) in individuals with compro-
mised barrier function56, whereas pTregs have shown enhanced
suppressive capacity against the same disease12. This is a perti-
nent feature given the relatively high proportion of subjects with
metabolic complications co-suffering from IBD57. While our
study was not designed to assess IBD susceptibility, it is well
described that purified diets compromise barrier function47,58,59
and thus represent clinical IBD-features (disease-cause) preceding
inflammation (symptom)60. In addition to the immunomodu-
lating phenotype, WDMcB-feeding augmented neutral mucus
production in all segments of the colon while enhancing IBD-
protective sulfomucins specifically in the middle segment. In this
segment, we also detected increased CD in WDMcB-fed mice,
collectively pointing towards increased barrier function.
pTregs were most recently described to be transferred from
mother to offspring via nongenetic inheritance through
breastmilk IgA; a trait transmitted during a tight age window after
birth but stable for life, and resistant to many microbial or cellular
perturbations61. It is thus striking to note the pronounced and
reproducible induction we here report in both SI- and LI-LP in
three substrains of mice from different vendors. Unfortunately,
we have not investigated the B cell component of the immune
system in this study, and thus, we cannot conclude on the extent
to which pTreg induction relies on B cells, McB lysate per se or the
McB-induced SCFAs and/or gut microbial changes. It is, however,
worth noting that apart from IgA-induced pTreg-control in early
life, other reports have also convincingly demonstrated that this
cell subset can be induced by bacterial metabolism of bile
acids62,63 as well as microbe-derived SCFAs in general54 and
butyrate in particular64. The latter of which we found abundantly
increased upon WDMcB feeding.
In summary, this study demonstrates a consistent activation of
IL-10+/IL-17+ pTregs throughout the gastrointestinal tract and a
reversion of gut dysbiosis in response to WDMcB feeding, even in
the context of high dietary fat and sucrose intake. The prospects
of using bacterial lysates as an alternative to traditional live
probiotics merit further investigation, just as future studies are
warranted to assess to what extent our results can be translated to
humans. Future studies are also urgently needed to identify the
biological effector molecule(s) in this bacterial lysate, with a
potential for being developed into a medical product(s) rebalan-
cing intestinal immunity while targeting gut-related dysbiosis and
metabolic abnormalities.
Methods
Mice and ethical statements. All experiments were conducted in accordance with
the EU directive 2010/63/EU as approved by the Danish Animal Experiments
Inspectorate (#2014-15-2934-01,027). Six- to seven-week-old male C57BL/
6JBomTac, C57BL/6JRj, C57BL/6 N, C57BL/6N-Rag2Tm1/CipheRj (RAG2−/−)
mice were acquired from Taconic Laboratories, Denmark, or Janvier Labs, France,
respectively, as detailed below. All mice were allowed to acclimatize on regular
chow diet for the first week upon arrival and then fed a low fat diet (LFD) for
Fig. 6 WDMcB treatment improves colonic mucus production and reverses obesity-induced gut microbiota changes to resemble the composition found
in lean LFD-fed mice. A Colon length in centimeters. Statistical significance compared to WDREF group by Kruskal–Wallis test, adjusted for multiple
comparisons by Dunn’s post-hoc. n= 10 (LFD and WDMcB) or 9 (WDREF). B Area of neutral mucins determined by Periodic Acid Schiffs (PAS) staining in
three discrete locations, i.e., proximal, middle, and distal colon segments. Three longitudinally sectioned crypts were measured in each sample (one data
point) at each location. Statistical significance compared to WDREF group by one-way ANOVA, adjusted for multiple comparisons by Dunnett post-hoc, for
proximal and distal segments while middle segment was by Kruskal–Wallis test, adjusted for multiple comparisons by Dunn’s post-hoc. n= 9 (LFD and
WDREF) or 10 (WDMcB) except for distal segment where n= 9 for WDMcB. C Colon crypt depth (CD) in proximal, middle, and distal colon segments,
measured in histological sections. Measurements are given in µm, and results are given as means of six crypt measurements per location per individual
mice (3 longitudinally PAS stained and HID-AB stained crypts, respectively, per data point). Statistical significance compared to WDREF group by one-way
ANOVA, adjusted for multiple comparisons by Dunnett post-hoc test. n= 10 (LFD and WDMcB) or 9 (WDREF). D PAS staining for mucus in colon middle
segments. One representative picture per group, as indicated, out of 9 (LFD and WDREF) or 10 (WDMcB) middle segment colon sections. E Area of
sulfomucins in proximal, middle, and distal colon segments by HID staining. Three longitudinally sectioned crypts were measured in each sample and at
each location. Statistical significance compared to WDREF group by one-way ANOVA, adjusted for multiple comparisons by Dunnett post-hoc, for proximal
and middle segments while distal segment was by Kruskal–Wallis test, adjusted for multiple comparisons by Dunn’s post-hoc. LFD n= 10, WDREF n= 8
except proximal segment where n= 9, and WDMcB n= 10 except for proximal segment where n= 9. F Area of sialomucins in proximal, middle, and distal
colon segments by AB staining. Three longitudinally sectioned crypts were measured in each sample and at each location. Statistical significance compared
to WDREF group by one-way ANOVA, adjusted for multiple comparisons by Dunnett post-hoc, for proximal and middle segments while distal segment was
by Kruskal–Wallis test, adjusted for multiple comparisons by Dunn’s post-hoc. LFD n= 10, WDREF n= 8 except proximal segment where n= 9, and WDMcB
n= 9 except for middle segment where n= 10. G Representative HID-AB staining of middle segment of indicated experimental group. One representative
picture per group out of 10 (LFD and WDMcB) or 8 (WDREF) evaluated sections. H PCoA of fecal microbiota composition of indicated group before (Week
21+ 0) and after (21+ 5) dietary intervention with group mean indicated as centroids. Microbiota composition was significantly different between the
WDREF and WDMcB groups at the end of the experiment week 21+ 5 (PERMANOVA p= 0.001). I Taxasummary of most abundant bacterial genera
showing mean relative abundance of indicated genera in each group at indicated timepoint. J Firmicutes/Bacteroidetes ratio of fecal samples of individual
mice at termination (Week 21+ 5). Statistical significance compared to WDREF group by one-way ANOVA, adjusted for multiple comparisons by Dunnett
post-hoc test. n= 10 (LFD and WDMcB) or 9 (WDREF). K Deseq analysis of fecal bacterial genera abundances significantly regulated by McB intervention
(p.adj. < 0.05). Relative abundance in % in each group and variation are shown for each regulated genera at the sampled time points. Fold-change and
adjusted p values of individual genera are indicated in Supplementary Table 5. A–K n= 8–10. A–C, E, F, J) Bars represent group mean ± SEM and dots
indicate individual data points. All p-values < 1 × 10−1 between WDREF and indicated group are depicted.
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2 weeks prior to study initiation. Mice were kept under specific pathogen free
conditions at 22 °C (T22°C) or 30 °C (T30°C), as indicated, in 12 h light/dark cycle
(6AM–6PM).
Housing, diets, and experimental setup. Standard pelleted diets as well as
protein-free western diet (WD) powder were obtained from Ssniff Spezialdiäten
GmBH, Germany, and stored at −20 °C throughout the duration of the experi-
ment. Mice were fed a compositionally defined low fat diet (LFD, S8672-E050)
until study initiation. A subgroup remained on LFD, whereas the remaining mice
were transferred to a soy oil based reference WD (S8672-E025) (high fat, high
sucrose, containing 0.15% cholesterol) for the run-in period (12 or 21 weeks
dependent on the experiment). Experimental WDs were lot-matched and produced
without protein (S9552-E021), which was subsequently added, and then pelleted,
by the investigators as indicated; WDREF= containing 19.5% (w/w) casein,
WDCNTL= containing 16.5% (w/w) casein and 3% Macadamia oil, WDMcB=
19.5% (w/w) whole-cell bacterial lysates (predominantly protein but up to ~15%
phospholipids31). Diet composition is more extensively described in Supplemen-
tary Table 1 with amino acid composition presented in Supplemetary Fig. 1f.
Detailed description of bacterial lysates is provided in the designated section below.
Fig. 7 McB lysates rely on adaptive immunity to boost Parabacteroides. A, B Taxasummary of most abundant bacterial genera showing mean relative
abundance of indicated genera in each group at indicated timepoint in WT (A) and RAG2−/− (B) mice. C, E Relative abundance of Parabacteroides in fecal
samples of indicated genotype at indicated timepoint. D, F Weighted UniFrac distance (instability test) between paired samples from indicated 2-weeks
interval post dietary intervention in WT (D) and RAG2−/− (F) mice. C–F Bars represent group mean ± SEM and dots indicate individual data points. All
p-values < 1 × 10−1 between WDREF and indicated group are depicted. Statistical significance compared to WDREF by two-way ANOVA-RM, adjusted for
multiple comparisons by Dunnett post-hoc. G, H PCoA of fecal microbiota composition of indicated group at baseline (Week 0, all mice fed LFD) and after
2, 4, and 6 weeks of dietary intervention with group mean indicated as centroids.
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All diets were freshly made for each experiment with independent batches of
bacterial lysates to substantiate robustness and reproducibility of the observed
findings. Mice were fed ad libitum, and feed intake was measured thrice a week.
Water was changed weekly.
12+ 6 protocol T22°C. Experimental setup is outlined in Supplementary Fig. 1a.
C57BL/6JRj mice were purchased from Janvier Labs, France, and housed three
mice per cage, reproduced in two independent experiments. For transparency, all
data are depicted in respective graphs with mean ± SEM plus individual dots for the
combined results of the two independent experiments. Experiment-dependent
shapes enable visual discrimination of respective experiments as well as data dis-
tribution within and between experiments.
21+ 5 protocol T30°C. Experimental setup is outlined in Supplementary Fig. 1b.
C57BL/6JBomTac mice were purchased from Taconic Laboratories, Denmark, and
initially housed 10 per cage to accelerate weight gain. Twelve weeks into the run-in
period, mice were single caged to allow accurate assessment of food intake, and also
monitor if the more sensitive microbiota of single-housed mice would uniformly
change towards a composition typical for LFD-fed mice, or if such phenomenon
relied on a few highly responding mice transferring their microbiota to cage mates
under group housed conditions. The timing of single housing allowed affected mice
to adapt to social isolation and stabilize their weight development before inter-
vention (Supplementary Fig. 5b).
Prophylactic protocols. Experimental setup is outlined in Supplementary Fig. 1c, d.
C57BL/6N-Rag2Tm1/CipheRj (RAG2−/− mice) and matched C57BL6/N WT mice
were purchased from Janvier Labs, France, and housed three mice per cage at
thermoneutrality, acclimated on LFD and from 9 weeks of age fed the experimental
diets for 6–7 weeks depending on genotype (see Supplementary Fig. 1c, d for
details). This was reproduced in two independent experiments analogous to the
12+ 6 protocol described above.
Cecal microbiota transfer (CMT) protocol. Experimental setup is outlined in Sup-
plementary Fig. 1e. C57BL/6JBomTac mice were purchased from Taconic
Laboratories, Denmark, and housed three mice per cage at thermoneutrality,
reproduced in two independent experiments. Experiment-dependent shapes enable
visual discrimination of respective experiments as well as data distribution within
and between experiments. We used mice from the 21+ 5 protocol as donors of
their cecal microbiota, ensuring transfer between genetically identical mice hence
limiting obvious confounders. Cecal microbiota transfer (CMT) was performed as
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-21408-9 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:1093 | https://doi.org/10.1038/s41467-021-21408-9 | www.nature.com/naturecommunications 15
after one week of antibiotic (ABX) treatment. Specifically, mice were housed in
disposable IVC cages with free access to sterilized water and LFD during the
2 weeks of acclimatization. They were then treated with a two-leg ABX mixture
(1 and 0.5 g ampicillin and neomycin, respectively, per liter water, changed thrice
weekly) for seven days while remaining on LFD. After ABX treatment, experi-
mental mice were fasted for 2 h and subsequently gavaged with Polyethylene Glycol
(Gangiden, Sandoz) to clean the intestines from potential remnants. Six hours later,
mice received the first of three boluses of cecal microbiota from either LFD-,
WDREF-, or WDMcB-fed donors. Cecal microbiota were pooled from all mice of the
respective groups before transfer. Immediately after first CMT, mice were divided
into either LFD- or WDREF-fed recipients and fed their respective diets for addi-
tionally 5 weeks.
Cultivation of M. capsulatus Bath and preparation of bacterial lysate. Methy-
lococcus capsulatus Bath (NCIMB 11132) was cultivated in nitrate mineral salts
(NMS) medium to produce the single-strain bacterial lysate. NMS medium was
composed from 5 stock solutions; 10× NMS Salts (98.9 mM KNO3, 43.8 mM
MgSO4*6H2O and 9.0 mM CaCl2), 1000× NaMoO4*2H20 (1.07 mM), 10,000×
FeEDTA (103 mM), 1000× Trace Elements Solution (0.8 mM CuSO4*5H20,
1.8 mM FeSO4*7H20, 1.4 mM ZnSO4*7H20, 0.24 mM H3BO3, 0.21 mM
CoCl2*6H20, 0.74 mM EDTA-Na2, 0.1 mM MnCl2*4H20, 42.07 uM NiCl2*6H20)
and 10× phosphate buffer pH 6.8 (198.25 mM Na2HPO4*12H20, 191.05 mM
KH2PO4). When preparing 1× NMS medium from stock solutions 10x NMS Salts
was add to 50% of the final volume with H2O before the remaining stock solutions
were added. Then pH was adjusted to 6.8 before the NMS medium was sterile
filtered using a 0.45-uM filter. Medium was stored in the dark.
The 1000× Trace Element Solution was made from the following stock solutions
and stored in the dark; 400.5 mM CuSO4*5H20, 3.6 mM FeSO4*7H20 (pH 3.0),
347.8 mM ZnSO4*7H20, 161.7 mM H3BO3, 42.0 mM CoCl2*6H20, 50.5 mM
MnCl2*4H20 and 42.0 mM NiCl2*6H20. McB culture aliquots were frozen in liquid
nitrogen and stored at −80 °C. Cultivations on agar plates and in shake flasks
(orbital shaker incubator at 200 rpm) were performed at 45 °C in an atmosphere of
75% air, 23.25% CH4, and 1.25% CO2. Continuous cultivation was carried out in a
3-l bioreactor (Applikon, The Netherlands) with a working volume of 2 l. Cells
were precultivated in shake flasks and used to inoculate the bioreactor to an optical
density at 440 nm (OD440) of 0.1. The temperature was maintained at 45 °C,
stirring set to 650 rpm, and pH maintained at 6.8 by automatic addition of 2.5 M
NaOH/2.5 M HCl. A gas mixture of 75% air and 25% methane was sparged into the
bioreactor. The continuous culture was started after an initial batch phase, and the
dilution rate was set to 0.01 h−1. The OD440 at steady state was generally sustained
at ~10. Culture effluent was collected, and cells were harvested by centrifugation.
Bacterial cell walls were disrupted by the use of a French press before freeze-drying
of the material.
Glucose and insulin tolerance tests. Mice were subjected to magnetic resonance
(MR)-scan using EchoMRI 4in1 (Texas, USA) to determine fat- and lean mass at
indicated time points (Supplementary Fig. 1a–d). Mice were fasted 5 or 2 h prior to
any oral glucose tolerance (OGTT) or intraperitoneal insulin tolerance test (ITT),
respectively. Fasting blood glucose was measured by tail vein bleeding using the
Bayer Contour glucometer (Bayer Health Care). Mice were subsequently gavaged
with 3 µg glucose/g lean mass (OGTT) or intraperitoneally injected with 0.75 mU
insulin/g lean mass (ITT). Blood were sampled at specified time points for blood
glucose and insulin measurements to assess glucoregulatory capacity including
glucose-stimulated insulin secretion (GSIS) as described in detail elsewhere28.
Short chain fatty acid measurements. Short chain fatty acids (SCFAs) were
determined by gas chromatographic analysis. Feces were suspended in MilliQ water
(1:1 (w/v)) and subsequently homogenized in a FastPrep-96 (MP Biomedicals)
sample preparation unit. The homogenates were diluted with 0.4% formic acid (1:1
(v/v)), transferred to Eppendorf tubes and centrifuged at 16,200 rcf for 10 minutes.
300 μl of the supernatants were applied to spin columns (VWR, 0.2 μm pore size)
and centrifuged at 9560 rcf for 5 minutes. The eluates were transferred to 300-μl
GC vials. Split injection mode was used with an injection volume of 0.2 μl. The gas
chromatograph was a Trace 1310 (Thermo Scientific) equipped with an auto-
sampler and a flame ionization detector. Helium was used as carrier gas, and the
column was a 30 m long Stabilwax (Restek) with polyethylene glycol as stationary
phase. Injector temperature: 250 °C, temperature intervals: 2 min at 90 °C before a
6 min increase to 150 °C, then a 2 min increase to 245 °C and a hold at this
temperature for 4.9 min. Detector temperature: 275 °C.
RNA extraction and quantitative RT-PCR. Frozen liver tissue was cryo-grinded
by mortar and pestle on liquid nitrogen and total RNA was extracted by TRIr-
eagent (Sigma–Aldrich, USA) according to the manufacturer’s protocol using
PRECELLYS® 24 for homogenization. One microgram of RNA was transcribed
into cDNA by reverse transcriptase (Invitrogen, USA). Quantitative PCR analyses
were performed using the SYBR Green qPCR Master mix (Thermo Scientific, USA)
and the Stratagene Mx3000P qPCR System. Standard curve and no template
control (NTC) were included on every 96-well plates. Validation of each target was
based on Rsq of standard curve >0.995, amplification efficiency of 100 ± 10% and
singular peak. Ct values for each target were related to 18 S reference Ct values of
the same sample by 2ΔCt and visualized as fold-change to the LFD reference group
mean. Primer sequences are summarized in Supplementary Table 2.
Histology. Liver tissue was sampled promptly after euthanasia, fixed in 10% for-
malin and subsequently embedded in paraffin prior to sectioning according to
standard procedures for light microscopy. Colon was emptied for content and
subsequently rolled around a 27 G needle after which the generated Swizz Rolls
were carefully preserved in liquid nitrogen (wrapped in aluminum foil) until
paraffin embedding. Embedded tissues were cut 2-µm thick, and sections mounted
onto glass slides. These sections were processed further and stained either with
hematoxylin and eosin (H&E), Oil Red O, PAS, or HID-AB, or labelled with
antibody of interest for immunohistochemical investigations, as detailed below.
Samples were randomized and blinded to the pathologists performing the histo-
logical analyses.
Liver. Nonalcoholic fatty liver disease activity score (NAS). Liver sections were
prepared by standard protocols and subsequently assessed by two independent
observers in a blinded fashion, using the established NAFLD activity score (NAS)
for evaluation of H&E stained liver sections65. In short, score of 0–2 excludes
nonalcoholic steatohepatitis (NASH), a score of 3–4 defines “borderline NASH”,
and score ≥5 is considered as NASH.
Fig. 8 Altered gut microbiota by WD feeding affects glucose regulation. A, C OGTT in 5 h fasted RAG2-/- mice after 1 and 6 weeks of dietary intervention
as indicated. Statistical significance compared to WDREF by two-way ANOVA-RM, adjusted for multiple comparisons by Dunnett post-hoc. n= 12 mice per
group. B, D Glucose stimulated Insulin Secretion during OGTT after 1 and 6 weeks of dietary intervention. Statistical significance compared to WDREF by
mixed effects analysis RM, adjusted for multiple comparisons by Dunnett post-hoc. n= 12 mice per group except for WDMcB group at 120min in B, WDMcB
group at 60min in D, and WDREF group at 15 min in D where n= 11 due to insufficient sample material. E–G Body weight, fat mass and lean mass, as
indicated, at indicated time points post dietary intervention. Statistical significance of body weight compared to WDREF by mixed effects analysis RM,
adjusted for multiple comparisons by Dunnett post-hoc, and fat and lean mass by two-way ANOVA-RM, adjusted for multiple comparisons by Dunnett
post-hoc. n= 12 mice per group except for WDMcB group Week 1 in E where n= 9. H Cecum weight at termination. Statistical significance compared to
WDREF group by one-way ANOVA, adjusted for multiple comparisons by Dunnett post-hoc test. n= 7 (LFD and WDREF) or 11 (WDMcB). I Concentration of
short chain fatty acids in cecum from H. Statistical significance compared to WDREF group by Kruskal–Wallis test, adjusted for multiple comparisons by
Dunn’s post-hoc. n= 12 (LFD and WDMcB) or 10 (WDREF). J, K Body weight and fat mass development in ABX treated WT mice fed either LFD (grey bars)
or WDREF (blue bars), receiving cecal microbiota from indicated donor mice. Statistical significance compared to WDREF by two-way ANOVA-RM, adjusted
for multiple comparisons by Dunnett post-hoc. WD-fed mice n= 11 (LFD donor), 9 (WDREF donor), and 12 (WDMcB donor). LFD-fed mice n= 12 (LFD
donor), 9 (WDREF donor), and 12 (WDMcB donor). L, N OGTT in 5 h fasted WDREF-fed WT recipient mice 1 and 5 weeks after first cecal microbiota transfer,
as indicated. Statistical significance compared to WDREF by two-way ANOVA-RM, adjusted for multiple comparisons by Dunnett post-hoc. LFD donor
n= 11, WDREF donor n= 9, and WDMcB donor n= 12. M, O Glucose stimulated Insulin Secretion during OGTT (L+N) 1 and 5 weeks after first cecal
microbiota transfer. Statistical significance compared to WDREF by two-way ANOVA-RM, adjusted for multiple comparisons by Dunnett post-hoc. In M,
LFD donor n= 11 except at 0 min where n= 4, WDREF donor n= 9 except at 0 min where n= 6, and WDMcB donor n= 12 except at 0 min where n= 9. In
O, LFD donor n= 10, WDREF donor n= 8 except at 90min where n= 9, and WDMcB donor n= 11 except at 90min where n= 12. Reduced n-size reflects
insufficient sample material at indicated timepoint. A–E, G, J, L–O Lines represent group mean and dots indicate individual data points. F, H, I, K Bars
represents mean ± SEM. Dots indicate individual data points. A–O All p-values < 1 × 10−1 between WDREF and indicated group are depicted.
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Oil Red O staining. Liver biopsies were fixed in paraformaldehyde, cryoprotected
in polyvinylpyrrolidone/saccharose, and frozen in liquid nitrogen. Cryosections
were prepared and stained using the lipid-specific Oil red O (Sigma–Aldrich,
Germany) and analyzed under an Axio Imager M2 microscope. Images were
captured with the Axiocam 506 color camera (Zeiss, Jena, Germany). Areas of
stained lipids were determined using ImageJ-1.50i software (https://imagej.nih.gov/
ij/index.html).
Colon. The morphological and morphometrical evaluations of the colonic tissues
were performed in a blinded fashion, and all measurements were made by the same
trained pathologist. One H&E stained section of colon from each individual was
evaluated histologically for any sign of pathology. To assess the quality of the
mucins, colonic tissues were stained for acidic as well as neutral mucins. Neutral
mucins were stained by Periodic Acid Schiffs (PAS). Acidic mucins were stained
through a combination of High Iron Diamine (HID), for sulfated mucins (sulfo-
mucins), and Alcian Blue (AB) for carboxylated mucins (sialomucins). Crypt depth
(CD) measurements, as well as analyses of mucin type and amount, were per-
formed on HID/AB- and PAS-stained sections in three histologically distinct areas
of the colon, i.e., the proximal, middle and distal area. At each of these three
locations, three longitudinally sectioned crypts were measured. Each data point is
thus presented as an average of three (mucin type and amount) or six (CD)
measures. Crypts were selected only when the entire crypt epithelium was visible
from the lamina muscularis mucosae to the lumen. The histological sections of the
colon were examined in an Axio Imager Z2 microscope (Zeiss, Jena, Germany),
and digital images were obtained using an Axiocam 506 color camera (Zeiss, Jena,
Germany). Micrographs were captured with the same ×20 objective magnification.
Crypt depth measurements were performed using the software program Image
J-Fiji version 1.52e Java 1.8.0_18166. For quantitative evaluation and automated
scoring of the different mucin types, a plugin for color deconvolution for the Image
J-Fiji program was used67.
Hepatic lipidomics. Samples were randomized and lipid extracted following
standard protocols. In short, 50 mg of frozen tissue were homogenized in a pre-
chilled 2 mL tube added 0.5 mL of ice-cold 50% MeOH with ~40 µM D5-
tryptophan following standard protocols and stored at −80 °C until LCMS analysis.
The peaklist obtained after preprocessing (features defined by their mass/charge
value, retention time and peak area) was analyzed in MetaboAnalyst 4. Data were
then auto-scaled (mean-centering and division by the square root of standard
deviation of each variable) to enforce Gaussian distribution enabling relative
comparison. Univariate and multivariate analysis were performed with t-tests,
volcano plot, analyses of variance (ANOVA) followed by Tukey’s HSD test, and
principal component analysis (PCA) to detect significant hits and to visually
separate trends between groups. Features showing a similar pattern between LFD
and WDMcB were identified by pattern matching function. The top 25 features
obtained were then processed for identification using the online database Lipid-
maps (http://lipidmaps.org) with a mass tolerance between the measured m/z value
and the exact mass of 3 ppm.
Microbiome analysis and bioinformatic processing. Fresh feces samples were
collected 3–4 h into the light cycle, snap frozen and stored at −80 °C until
downstream processing. Bacterial DNA from fecal samples was extracted using a
NucleoSpin soil kit (Macherey-Nagel) according to manufacturer’s instructions. 16
S rRNA gene amplification was performed using 515 F and 806 R primers and
sequenced with 250PE on Ilumina MiSeq. USEARCH68 and mothur69 were used
for the processing of the sequence data. Sequences were strictly dereplicated, dis-
carding clusters smaller than 5. Sequences were clustered at 97% sequence simi-
larity. Additional suspected chimeric operational taxonomic units (OTUs) were
discarded on the basis of comparison with Ribosomal Database Project classifier
training set v917 using UCHIME70. Taxonomic assignment of OTUs was done
using the database from Ribosomal Database Project17. Initial data processing was
performed as described elsewhere71. Data was rarefied to 23,107 reads per sample.
The principal coordinate analysis (PCoA) was conducted based on the weighted
UniFrac distance. To select OTUs and species enriched in different subgroups,
DESeq272 with default settings was used. The relative abundances of OTUs were
aggregated to genus level. Genera present in >1/3 of the samples were used in the
differential abundance testing. Genera with p.adj. < 0.05 comparing the last sam-
pling point for WDREF/WDCNTL vs WDMcB with DESeq2 differential expression
analysis based on the negative binomial distribution were reported. Permutational
multivariate analysis of variance (permanova) using weighted UniFrac distance
matrices (Adonis, Vegan R package) was used to evaluate overall microbial
compositions.
Isolation of small intestine (SI) and large intestine (LI) lamina propria (LP)
cells. Feces and mucus from LI were scraped off while SI was flushed with 1× HBSS
(Gibco) containing 15 mM HEPES (Thermo Fisher Scientific). Peyer´s patches
were carefully excised from SI. SI and LI were opened longitudinally, cut into
approx. 1 cm pieces and washed three times with 1× HBSS (Gibco) containing 15
mM HEPES (Thermo Fisher Scientific), 5% FCS (ViralexTM, PAA Laboratories),
50 µg/mL gentamycin (Gibco), and 2 mM EDTA (Invitrogen, Life Technologies)
for 15 min at 37 °C. During the first incubation step, 0.15 mg/mL DL-dithiothreitol
(Sigma–Aldrich) was added to LI samples. LI, but not SI samples, were shaken on
an orbital shaker at 350 rpm during incubation. After each incubation step, SI, but
not LI samples, were shaken by hand for 10 s. Media containing epithelial cells and
debris were discarded by filtration through a 250 µm mesh (Tekniska Pre-
cisionsfilter, JR AB). The remaining tissue was digested for 20–28 min at 37 °C
under magnetic stirring (350-500 rpm) in R-10 media (RPMI 1640 (Gibco) with
10% FCS (Viralex, PAA Laboratories), 10 mM HEPES (Thermo Fisher Scientific),
100 U/mL penicillin (Gibco), 100 µg/mL streptomycin (Gibco), 50 µg/mL genta-
mycin (Gibco), 50 µM 2-mercaptoethanol (Gibco), and 1 mM sodium pyruvate
(Gibco)) containing 1 mg/ml collagenase P (Roche) and 0.03 mg/mL DNase I
(Roche). After digestion, SI-LP and LI-LP cells were purified by density gradient
centrifugation (600 rcf for 20 min at 22 °C, acceleration 5 and brake 0) with 40/70
% Percoll (GE Healthcare). Cell suspensions were subsequently filtered through
100 µm cell strainers (BD Biosciences) and restimulated in vitro prior to staining
for flow cytometric analysis.
Isolation of liver cells. To isolate liver cells, livers were collected from 1× PBS
(Gibco)-perfused mice, cut into small pieces and digested for 40 min at 37 °C in R-
10 media (RPMI 1640 (Gibco) with 10% FCS (Viralex, PAA Laboratories), 10 mM
HEPES (Thermo Fisher Scientific), 100 U/mL penicillin (Gibco), 100 µg/mL
streptomycin (Gibco), 50 µg/mL gentamycin (Gibco), 50 µM 2-mercaptoethanol
(Gibco), and 1 mM sodium pyruvate (Gibco)) containing 0.3 mg/ml collagenase IV
(Roche), 0.21 mg/mL collagenase D (Roche) and 0.05 mg/mL DNase I (Roche) on
an orbital shaker (370 rpm). After digestion, liver cells were filtered through 100
µm cell strainers (BD Biosciences) and subsequently purified by density gradient
centrifugation (800 rcf for 20 min at 22 °C, acceleration 5 and brake 0) with 40/70%
Percoll (GE Healthcare). Cell suspensions were either restimulated in vitro prior to
or directly used for flow cytometric analysis.
Ex vivo stimulation of SI-LP, LI-LP, and liver cells. SI-LP, LI-LP, and liver cells
were restimulated in vitro in R-10 media in the presence of either 20 ng/mL IL-23
(R&D Systems) or 250 ng/mL PMA (Sigma–Aldrich) in combination with 0.5 µg/
mL ionomycin (Sigma–Aldrich) for 4 h at 37 °C. After 1 h incubation, 10 µg/mL
brefeldin A (BioLegend) was added.
Flow cytometry. Flow cytometry was performed according to standard proce-
dures. Cell aggregates (identified in FSC-H or FSC-W vs. FSC-A scatter plots) and
dead cells identified by using Zombie Aqua or Zombie UV Fixable Viability Kit
(BioLegend) were excluded from analyses. Intracellular staining was performed
using the eBioscience FoxP3/Transcription Factor Staining Buffer Set (eBioscience)
according to the manufacturer’s instructions. Data was acquired on a LSRII (BD
Biosciences) and analyzed using FlowJo software (Tree Star).
Antibodies (Abs) and reagents. The following mAbs and reagents were used in
the study: anti-CD3ε (17A2), anti-CD4 (GK1.5), anti-CD8α (53-6.7), anti- CD11b
(M1/70), anti-CD11c (N418), anti-CD19 (6D5 and ID3), anti-CD45 (30F11), anti-
CD45R/B220 (RA3-6B2), anti-CD90.2 (30-H12), anti-CD127 (A7R34), anti-Ly-
6G/Ly6C (Gr-1) (RB6-8C5), anti-Ly6C (AL-21), anti-Ly-6G (1A8), anti-TER-119
(TER-119), anti-F4/80 (BM8), anti-I-A/I-E (M5/114.15.2), anti-Siglec-F (E50-
2440), anti-TIM-4 (54(RMT4-54)), anti-TCRβ (H57-597), anti-TCRγδ (GL3), anti-
NK1.1 (PK136), anti-NKp46 (29A1.4), anti-FoxP3 (FJK-16s), anti-RORγt (B2D),
anti-T-bet (4B10), anti-Ki67 (B56), anti-IL-10 (JES5-16E3), anti-IL-17A (TC11-
18H10.1), anti-IL-22 (IL22JOP), and anti-IFNγ (XMG1.2). All Abs were purchased
from eBioscience, BioLegend or BD Biosciences. PECF594-conjugated and BV421-
conjugated streptavidin were purchased from BD Biosciences and BioLegend,
respectively.
Multiplex cytokine quantification. Liver tissues were crushed with a mortar and
pestle on liquid nitrogen. 30–40 mg of tissue were transferred to a clean tube and
400-µL T-PER tissue protein extraction reagent (Thermo Scientific) buffer
including proteinase inhibitors (Sigma–Aldrich) were added. Protein concentration
was assessed by BCA (Thermo Scientific) according to manufacturer’s instruction.
Cytokines were quantified using xMAP technology with combinations of Bio-Plex
Pro (BioRad) premixed mouse cytokine panels, and the analyses were carried out
on a Bio-Plex 200 system and the Bio-Plex Manager Software package.
Statistical analysis. Omics data were acquired as described in their appropriate
sections. Normality residuals of remaining data were assessed by D’Augostino-
Pearson omnibus (k2), Graphpad Prism 8, and subsequently evaluated by para-
metric (gaussian distributed) or non-parametric (non-gaussian distributed) tests as
appropriate. Details of each test including post-hoc assessment are specified in
figure legends. Data are expressed as indicated in individual figure legends, and all
groups are compared by two-sided tests to the relevant WDREF or WDCNTL group
as indicated.
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Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All data are in this manuscript are available on reasonable request to the corresponding
authors. 16S sequencing data are uploaded to a public repository with study accession
number: PRJEB41983 and available at the following link: http://www.ebi.ac.uk/ena/data/
view/PRJEB41983. All non-omics datasets included in the current study are available in
the figshare repository Jensen, B. A. H. et al. Data underlying the manuscript: Lysates of
Methylococcus capsulatus Bath induce a lean-like microbiota, intestinal FoxP3+RORγt
+ IL-17+ Tregs and improve metabolism. figshare https://doi.org/10.6084/m9.
figshare.13522283 (2021).
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